rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

GlaxoSmithKline Pharmaceuticals Ltd.

500660 GLAXO Group (A)

25 Nov,10:08
2436.75
21.55 (0.89%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL

776 2,415.20 2,484.50 - 2,427.90 3,087.95 - 1,615.65 41,278.55
(Rs. Crore)

Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,407.253,216.343,217.513,193.733,224.68
Operating profit900.65799.41755.83694.95658.45
Interest1.801.811.993.536.34
Gross profit1,022.33899.12830.06801.61729.67
EPS (Rs)34.5135.8799.7921.116.50

See more in Research Center »

About GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia

News for Pharmaceuticals and health care

Rupee Rises 6...
Rupee Rises 6 Paise to 84.35 vs US Dollar - News
Indian Rupee strengthened against the US Dollar in early trade, supported by positive domestic equities. Read more about the factors influencing the USD/INR exchange rate.
Nov 25, 2024 10:04
Adani Group:...
Adani Group: Strong Financials, No External Debt Needed
Adani Group boasts robust profits and cash flows, demonstrating its ability to fund growth without external debt. The group's strong financial position and low debt levels are highlighted in a...
Nov 25, 2024 08:37
Gold Prices Surge...
Gold Prices Surge to Rs 80,000 Amid Geopolitical Tensions
Gold prices have rebounded to Rs 80,000 per 10 grams in India, driven by rising geopolitical tensions and a weak US dollar. Analysts expect continued bullish sentiment for the precious metal.
Nov 24, 2024 19:36
India's Mobile...
India's Mobile Exports Soar: Airports Need Capacity Boost
India's mobile phone exports are set to boom, reaching USD 180 billion by 2030. However, the country's airports are struggling to keep up with the demand for cargo handling capacity. Industry...
Nov 24, 2024 17:44
US SEC Can't...
US SEC Can't Directly Summon Adani: Sources
The US SEC will have to serve summons on Gautam Adani and Sagar Adani through diplomatic channels due to lack of jurisdiction over foreign nationals. The summons are part of the legal docket filed...
Nov 24, 2024 16:22

More News »

Top News

Rupee Rises 6...
Rupee Rises 6 Paise to 84.35 vs US Dollar - News
Indian Rupee strengthened against the US Dollar in early trade, supported by positive domestic equities. Read more about the factors influencing the USD/INR exchange rate.
Nov 25, 2024 10:04
Adani Group:...
Adani Group: Strong Finances, No Need for External Debt
Adani Group highlights its robust financial performance, emphasizing its ability to fund growth through internal cash flow and minimal external debt.
Nov 25, 2024 09:53
Indian Students Flock to US Universities: Quality Education & Opportunities
Indian students are drawn to US universities for quality education, STEM opportunities, and a thriving Indian diaspora. Learn why the US is the top destination for Indian students.
Nov 25, 2024 09:25
Indian Students Flock to US Universities: Quality Education & Opportunities
Indian students are choosing US universities in record numbers, driven by quality education, STEM opportunities, and a thriving Indian diaspora. Learn why the US is a top destination for Indian...
Nov 25, 2024 09:25
Adani Group:...
Adani Group: Strong Financials, No External Debt Needed
Adani Group boasts robust profits and cash flows, demonstrating its ability to fund growth without external debt. The group's strong financial position and low debt levels are highlighted in a...
Nov 25, 2024 08:37

More Top News »

Report Card

PE Ratios
69.92
EPS (Rs.)
34.51
Sales (Rs. Cr)
1,000.05
Face Value (Rs.)
10
Net Profit Margin (%)
17.16
Last Bonus
1:1
Last Dividend(%)
120
Return on Average Equity
32.6

BSE Announcements from GlaxoSmithKline Pharmaceuticals Ltd. (See all)

announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 06 Nov 2024
announcement Announcement Under Regulation 30: Updates - 04 Nov 2024

Compare 'GlaxoSmithKline Pharmaceuticals Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,777.65
  • Compare
  • Divi's Laboratories Ltd.
  • 5,975.70
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,104.55
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,194.55
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,743.65
  • Compare
  • Max Healthcare Institute Ltd.
  • 989.65
  • Compare
  • Zydus Lifesciences Ltd.
  • 944.25
  • Compare
  • Aurobindo Pharma Ltd.
  • 1,220.20
  • Compare

Most Active

  • Change (Rs.)
  •  

GlaxoSmithKline Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in GlaxoSmithKline Pharmaceuticals Ltd.,     ago

You would have  Rs. 1,010.16 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close